The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kovalik, J.-P.
Right arrow Articles by Van Kaer, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kovalik, J.-P.
Right arrow Articles by Van Kaer, L.
The Journal of Immunology, 2000, 165: 1285-1293.
Copyright © 00 by The American Association of Immunologists

The Alloreactive and Self-Restricted CD4+ T Cell Response Directed Against a Single MHC Class II/Peptide Combination1

Jean-Paul Kovalik*, Nagendra Singh2,*, Sanjeev K. Mendiratta3,*, W. David Martin4,*, Leszek Ignatowicz{dagger} and Luc Van Kaer5,*

* Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232; and {dagger} Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA 30912


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The cellular basis for allograft rejection derives from the strong T cell response to cells bearing foreign MHC. While it was originally assumed that alloreactive T cells focus their recognition on the polymorphic residues that differ between syngeneic and allogeneic MHC molecules, studies with MHC class I-restricted CTL have shown that MHC-bound peptides play a critical role in allorecognition. It has been suggested that alloreactive T cells depend more strongly on interactions with the MHC molecule than with the associated peptide, but there is little evidence to support this idea. Here we have studied the alloreactive and self-restricted response directed against the class II H2-Ab molecule bound with a single peptide, Ep, derived from the H2-E{alpha} chain. This MHC class II-peptide combination was a poor target and stimulator of alloreactive CD4+ T cell responses, indicating that MHC-bound peptides are as important for alloreactive CD4+ T cells as they are for alloreactive CTL. We also generated alloreactive T cells with exquisite specificity for the Ab/Ep complex, and compared their reactivity with self-restricted T cells specific for the same Ab/Ep complex. Our results showed that peptide-specific alloreactive T cells, as compared with self-restricted T cells, were more sensitive to peptide stimulation, but equally sensitive to amino acid substitutions in the peptide. These findings indicate that alloreactive and self-restricted T cells interact similarly with their MHC/peptide ligand.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
T lymphocytes recognize foreign peptide Ags bound by self-MHC molecules, a property termed self-MHC restriction (1). Self-MHC restriction of T cell responses is acquired during the positive selection of immature T cells in the thymus (2, 3, 4). However, 1–10% of all T cells that are positively selected appear to be also capable of alloreactivity, i.e., to react strongly with MHC molecules expressed on allogeneic tissue to which they were not previously exposed (5, 6). This strong reactivity may, in part, be due to the inherent affinity of TCRs for MHC molecules (7, 8).

Precisely how alloreactive TCRs interact with their ligands remains controversial. In one model, it is proposed that T cells interact only with polymorphic residues that differ between the self and foreign MHC molecules and that the interaction with foreign MHC is not affected by the bound peptide (9). The high frequency of alloreactivity would then result from the high density of the allogeneic determinant as compared with the low density of a specific peptide bound with a self-MHC molecule. Some evidence for this model is available. For example, purified HLA-A2 molecules were able to stimulate alloreactive T cells in the absence of any bound peptide (10). In another study alloreactive T cell clones were isolated that recognize determinants on H2-Kb that are independent of peptide (11). In general, however, peptide-independent recognition has been difficult to detect and probably reflects only a small subset of alloresponses. In another model, it is proposed that alloreactive T cells recognize a complex between the foreign MHC molecule and an associated peptide (12). This foreign MHC/peptide combination mimics self-MHC plus foreign peptide. Numerous studies with MHC class I-restricted CTL support this hypothesis (5, 6, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27). Although some alloreactive T cells had a strict requirement for the type of peptide that associates with the foreign MHC (24, 25, 26, 27), most alloreactive CTL displayed substantial degeneracy for peptide recognition (19, 21, 22, 23).

A number of similarities and differences regarding the interaction of alloreactive and self-restricted T cells with MHC/peptide complexes have been noted. First, alloreactive T cells with very high affinity for their MHC ligand have been identified (28, 29). Second, it is unclear whether alloreactive and self-restricted T cells interact with MHC/peptide complexes in the same way. Crystallographic studies of TCR/self-MHC/peptide complexes have indicated a diagonal orientation of the TCR with respect to the MHC/peptide (30, 31, 32, 33, 34, 35). Despite the overall conservation of the TCR footprint in the different crystals, the actual positions of the TCR domains and the distribution of MHC vs peptide contacts varied widely. It also remains to be determined whether the overall orientation and the exact positions of complementarity determining region (5) loops with respect to MHC and peptide ligands of alloreactive TCRs is similar to that of self-restricted TCRs. Third, it has been argued that alloreactive T cells depend more strongly on interactions with residues located on the {alpha}-helices of the allo-MHC and less on interactions with peptide residues (28, 35, 36, 37, 38). This idea is supported by studies that compared the ligand requirements for self vs alloantigen recognition of different MHC alleles by a single T cell clone (28, 35, 36, 37, 38). However, a different conclusion was made in a recent study that compared self vs alloantigen recognition of a single MHC allele, H2-Ld, by a large panel of self-restricted and alloreactive CTL clones (39). Ld-restricted and Ld-alloreactive CTL were equally sensitive to changes in the sequence of the Ld molecule, indicating that self-restricted and alloreactive T cells are comparably dependent on MHC molecules. Thus, the overall dependence of alloreactive T cells for interaction with MHC vs peptide residues remains controversial.

Here, we have studied the alloreactive and self-restricted T cell response directed against the MHC class II molecule H2-Ab bound with a peptide derived from the H2-E{alpha}-chain (Ep)6. We first showed that among a large panel of alloreactive T cell clones generated against H2-Ab molecules bound with the normal wide array of peptides present in wild-type cells, only a small fraction was able to react with the H2-Ab/Ep complex. We also demonstrated that cells expressing only the H2-Ab/Ep complex are very poor stimulators of naive alloreactive CD4+ T cells in MLCs. We then raised a panel of alloreactive T cell hybridomas against the Ab/Ep complex. While the majority of these clones cross-reacted with wild-type H2b cells, some clones had exquisite specificity for this complex. Finally, we compared the ligand requirements of these Ab/Ep-specific alloreactive clones with the ligand requirements of a set of self-restricted T cell clones specific for the same class II/peptide complex. On average, alloreactive clones were more sensitive to stimulation by peptide than the self-restricted clones. However, both types of clones were equally sensitive to changes in the sequence of the Ep peptide. Collectively, these findings demonstrate the critical importance of MHC class II-bound peptides for recognition by alloreactive CD4+ T cells, indicate that the majority of alloreactive T cells can respond to multiple peptide ligands, and support the idea that peptide-specific alloreactive and self-restricted T cells have similar requirements for interaction with MHC and peptide.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Mice

AbEp invariant chain (Ii)-negative mice have been described (7). Ii mutant mice (40) on a C57BL/6 (B6) background were obtained from Dr. Elizabeth K. Bikoff (Harvard University School of Medicine, Boston, MA). H2-DM mutant mice (41) were bred to a B6 background in our laboratory. MHC class II mutant mice (42) on a B6 background were obtained from Drs. Diane Mathis and Christophe Benoist (Harvard University School of Medicine, Boston, MA). All of these mutant strains were maintained and bred under specific pathogen-free conditions in the animal facility at Vanderbilt University School of Medicine (Nashville, TN). B6 (H2b), BALB/c (H2d), SJL (H2s), RIII (H2r), and CBA/J (H2k) mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and maintained in our animal facility.

Peptides

The following peptides were used: the E{alpha}-derived peptide Ep52–68, ASFEAQGALANIAVDKA and its single amino acid substituted variants Ep55A, Ep56G, Ep59G, Ep61G, Ep63A, Ep64G, and Ep66A; a set of truncated versions of Ep52–68 that include Ep53–68, Ep54–68, Ep55–68, Ep56–68, Ep57–68, Ep52–67, Ep52–66, and Ep52–65. All of the peptides were >90% pure as shown by reverse-phase HPLC and mass spectrometry. Peptides were obtained from the biopolymer facility of the Howard Hughes Medical Institute at the University of Texas Southwestern Medical Center (Dallas, TX) and the Duke University School of Medicine (Durham, NC).

Mixed lymphocyte cultures

Primary MLRs were performed with spleen responder cells from naive mice depleted of CD8+ T cells. Depletion of CD8+ T cells was performed by staining with anti-CD8 Abs (clone 2.43) (obtained from Dr. Barney Graham, Vanderbilt University) followed by panning on plates coated with rabbit anti-rat IgG (Cappel, Organon Teknika, West Chester, PA). Purified responder cells (1 x 105) were then mixed with varying numbers of irradiated spleen stimulator cells for 3 days at 37°C. Cells were pulsed with 0.5 µCi [3H]thymidine (NEN Life Science Products, Boston, MA) followed by further culture for 16 h. [3H]Thymidine incorporation was measured by harvesting cells with a cell harvester (Tomtec, Orange, CT) and counting the amount of radioactivity with a betaplate reader (Wallac, Gaithersburg, MD).

Generation of T cell hybridomas

Mice were immunized i.p. with 2 x 107 irradiated (1000 rad) spleen cells from B6 or AbEpIi- mice. Seven to 10 days later, 5 x 107 spleen cells from these immunized animals were restimulated in vitro with 4–5 x 107 irradiated B6 or AbEpIi- spleen cells for 3 days. Cells were counted and fused with Bw5147 {alpha}-ß- cells (obtained from Dr. Willi Born, National Jewish Center, Denver, CO) using polyethylene glycol 1500 (Boehringer Mannheim, Indianapolis, IN). Hybridomas were obtained by plating fused cells in hypoxanthine/aminopterin/thymidine selection media (Boehringer) and later maintained in hypoxanthine/thymidine-containing media. Because cell fusions were plated under limiting dilution conditions, hybrids can be considered clonal.

T cell hybridoma stimulation assay

Hybrids were screened by coculturing a fixed number (1 x 105) of hybridoma cells with irradiated stimulators (1 x 105) in a final volume of 200 µl in a flat-bottom 96-well plate. After 24 h culture, 50-µl supernatants were harvested and assayed for the presence of IL-2 by using the IL-2-dependent cell line HT-2. The supernatants were mixed with 1 x 104 HT-2 cells and incubated at 37°C for 20 h. IL-2-dependent proliferation of HT-2 cells was tested by uptake of [3H]thymidine as described above. Reactivity of hybrids was graded as strong, weak, or none when they produced >50, 10–50, or <10%, respectively, of the IL-2 produced in the optimal response (against cells from B6 or AbEpIi- mice). To test sensitivity of hybrids to stimulation with peptide, fixed numbers of hybridoma cells (1 x 105) were cocultured with irradiated B6 splenic APCs (1–3 x 105) and with a titrated dose of the peptide Ep or one of its peptide variants. Reactivity against peptide variants was graded as strong, weak, or none when hybrids produced >50, 10–50, or <10%, respectively, of the IL-2 as produced by stimulation with the cognate Ep peptide. To test the sensitivity of hybrids to stimulation with anti-CD3, fixed numbers of hybridoma cells (1 x 105) were mixed with irradiated splenic APCs (5 x 105) from MHC class II mutant mice; titrated doses of supernatant containing anti-CD3 Ab (145-2C11) were then added to the cultures, and supernatants were tested for IL-2 content after 24 h of coculture as above.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
Few H2-Ab-specific alloreactive CD4+ T cells recognize APC from AbEpIi- mice

AbEpIi- mice express a single MHC class II-peptide combination, H2-Ab plus a peptide (Ep) derived from the H2-E{alpha}-chain (7). Cell-surface expression levels of the class II Ab molecules in these animals reach ~10% of wild-type mice (7). Because few studies have evaluated the role of MHC-bound peptides for allorecognition in the class II system, we first evaluated whether this unique class II-peptide combination is an efficient target for alloreactive CD4+ T cells. Therefore, we generated large panels of alloreactive H2-Ab-specific hybrids. Briefly, mice from a set of allogeneic strains (CBA, H2k; BALB/c, H2d; RIII/J, H2r; SJL, H2s) were immunized with irradiated spleen cells from B6 (H2b) mice, and after in vitro restimulation hybrids were generated under limiting dilution conditions. These clonal hybrids (nearly 500) were then tested for reactivity with APC from wild-type B6, H2-DM-deficient, Ii-deficient, AbEpIi-, and MHC class II-deficient mice (all from the H2b haplotype). MHC class II molecules in these mice display varying degrees of class II cell-surface expression levels and peptide diversity: in B6 mice Ab class II molecules are bound by a wide gemish of self-peptides; in H2-DM-deficient mice, Ab molecules are expressed at normal levels and are mostly bound by a peptide, CLIP, derived from the MHC class II-associated Ii chain (41, 43, 44), but some contamination by non-CLIP peptides has been noted (45, 46); in Ii-deficient mice, Ab surface expression is reduced ~10-fold, and these molecules are thought to be occupied by low-affinity peptides (40, 47, 48, 49); in AbEpIi- mice, Ab surface expression is reduced ~10-fold, and these complexes are bound by Ep (7); finally, MHC class II-deficient mice lack class II surface expression altogether (42, 50). The reactivity of these hybrids was graded strong, weak, or none, when IL-2 produced by the hybrids was >50, 10–50, or <10%, respectively, of the IL-2 produced when the hybrids were stimulated with wild-type B6 cells (Table IGo). Consistent with our previous findings (51), only a small percentage (9%) of the hybrids responded (strongly or weakly) to stimulator cells from H2-DM-deficient mice. Similarly, only 6% of the hybrids reacted with cells from AbEpIi- mice. While it is possible that some hybrids failed to react with AbEpIi- APC because of the reduced expression of class II molecules in these animals, this interpretation cannot explain the low frequency of reactivity. Indeed, cells from Ii-deficient mice, with similar class II surface levels, were recognized by most (93.5%) of the hybrids. Because none of the hybrids studied reacted with all MHC class II-expressing cells tested (i.e., cells from wild-type B6, Ii-deficient, H2-DM-deficient, and AbEpIi- mice), none of the hybrids fit the criterion for complete peptide independence of alloantigen recognition.


View this table:
[in this window]
[in a new window]
  		Table I. Summary of the reactivities of randomly selected alloreactive anti-H2-Ab hybridomas1

 
We conclude from these experiments that very few Ab-specific alloreactive T cells can react with the Ab/Ep complex expressed by AbEpIi- mice. These findings illustrate the critical importance of MHC-bound peptides for recognition of MHC class II by most alloreactive CD4+ T cells and indicate that truly peptide-independent alloreactive T cells must be rare.

Cells from AbEpIi- mice are poor stimulators of alloreactive CD4+ T cells in primary MLCs

To provide further evidence for the critical role of peptide in allorecognition, we tested whether APC from AbEpIi- mice can stimulate allogeneic CD4+ T cells in primary MLCs. Fig. 1Go shows that none of the four allogeneic strains tested generated a significant allo response against AbEpIi- cells. Likewise, consistent with our previous findings (51), cells from H2-DM-deficient mice were also poor stimulators of allogeneic CD4+ T cells.



View larger version (22K):
[in this window]
[in a new window]
  		FIGURE 1. Cells from AbEpIi- mice are poor stimulators of primary alloreactive CD4+ T cell responses. Splenic responder cells, isolated from the indicated allogeneic mouse strains and depleted of CD8+ T cells, were cocultured with titrated numbers of irradiated splenic stimulator cells from the indicated mice for 3 days. Proliferation of responder cells was measured by uptake of [3H]thymidine. Cell cultures were performed in duplicate. Similar results were obtained in two separate experiments.

 
Generation of Ab/Ep-specific alloreactive and self-restricted T cells

To generate alloreactive T cells with exquisite specificity for the Ab/Ep complex, mice from a panel of allogeneic strains were immunized with irradiated AbEpIi- APC, and T cell hybridomas were generated. The majority (83%) of these hybrids responded not only to AbEpIi- cells, but also to wild-type B6 APC, and many responded to Ii-deficient cells (Table IIGo). Hybrids with this type of reactivity lack strict specificity for the Ab/Ep complex. Instead, this type of reactivity may be consistent with peptide-independent alloreactivity. However, only one of the 13 hybrids tested within this group responded weakly to H2-DM-deficient stimulator cells, indicating that the recognition pattern of these hybrids is not completely independent of the bound peptide. Therefore, this group of hybrids represents clones with specificity for multiple peptides displayed by H2-Ab. A smaller percentage (17%) of the hybrids responded to stimulators from AbEpIi- mice but not to any of the other stimulator cells (Table IIGo and Fig. 2Go). Therefore, these hybrids have exquisite specificity for the Ep peptide bound with H2-Ab.


View this table:
[in this window]
[in a new window]
  		Table II. Summary of the reactivities of hybridomas obtained after immunization of allogeneic mice with cells from AbEpIi- mice1

 


View larger version (28K):
[in this window]
[in a new window]
  		FIGURE 2. Reactivities of self-restricted and alloreactive T cell hybridomas with exquisite specificity for the H2-Ab/Ep complex expressed by APC from AbEpIi- mice. The indicated hybrids (1 x 105 cells) were incubated with titrated numbers of irradiated splenic stimulator cells from B6, AbEpIi-, or MHC class II-/- mice. Stimulation of the hybridoma cells was measured by IL-2 production, as assayed by the proliferation of HT-2 indicator cells.

 
The same protocol was used to generate Ab/Ep-specific self-restricted T cells. In this case, wild-type B6 mice were immunized with irradiated AbEpIi- APC, and T cell hybridomas with specificity for AbEpIi- stimulator cells were isolated.

Both Ab/Ep-specific alloreactive and self-restricted hybridomas responded to stimulators from AbEpIi- mice in a dose-dependent manner and failed to react with APC from B6 mice (Fig. 2Go). Seventeen allogeneic hybrids from three different allogeneic strains and nine self-restricted hybrids were then compared for their sensitivity to stimulation with the Ep peptide and for their sensitivity to amino acid substitutions in the sequence of Ep.

Ab/Ep-specific alloreactive T cells are more sensitive to peptide stimulation than Ab/Ep-specific self-restricted T cells

Prior studies have suggested that the TCRs of alloreactive T cells are more sensitive to stimulation than the TCRs of self-restricted T cells (28, 29). Therefore, we compared the sensitivity of our alloreactive and self-restricted hybrids to stimulation with the Ep peptide. Hybrids were cultured with irradiated B6 APC that were pulsed with graded doses of the Ep peptide. Fig. 3Go shows that, on average, alloreactive hybrids were ~10 times more sensitive to stimulation by Ep than the self-restricted hybrids. In contrast, both types of hybrids were equally sensitive to stimulation with anti-CD3 Abs (data not shown). Thus, these findings are in general agreement with the prior studies (28, 29) and show that alloreactive T cells have lower activation thresholds than self-restricted T cells.



View larger version (23K):
[in this window]
[in a new window]
  		FIGURE 3. Alloreactive hybrids are more sensitive to stimulation by peptide than self-restricted hybrids. Hybrids (1 x 105 cells) derived from either B6, SJL, RIII, or BALB/c mice were incubated with a titrated dose of the Ep peptide in the presence of irradiated B6 APC (3 x 105 cells). Stimulation of hybridoma cells was measured by IL-2 production, as assayed by proliferation of HT-2 indicator cells. Each data point in the graphs represents the mean of duplicate wells.

 
Ab/Ep-specific alloreactive and self-restricted T cells are equally sensitive to truncation variants of the Ep peptide

Next, we compared the reactivity of alloreactive and self-restricted T cell hybrids to a set of truncation variants of the Ep peptide. Because the minimal binding sequence of Ep to H2-Ab contains residues 57–65 of the E{alpha} chain (52), no residues within this sequence were deleted. Reactivity of hybrids was graded as strong, weak, or none when IL-2 produced by the hybrids was >50, 10–50, or 10%, respectively, of the IL-2 produced when the same hybrid was stimulated with the full-length Ep peptide. Results indicate that alloreactive and self-restricted hybrids are equally sensitive to truncations at the N and C terminus of Ep (Fig. 4Go). Nearly all hybrids were sensitive to N-terminal truncations at amino acid positions 55 and 56, whereas only two self-restricted hybrids were partially sensitive to C-terminal truncations. These studies indicate that the minimal peptide length requirement for most self-restricted and most allogeneic TCRs is residues 55–65. These findings also indicate that allogeneic and self-restricted hybrids recognize the Ep peptide bound to the H2-Ab groove in the same binding register.



View larger version (33K):
[in this window]
[in a new window]
  		FIGURE 4. Self-restricted and alloreactive hybrids react similarly to truncated variants of the Ep peptide. The indicated hybrids (1 x 105 cells) were incubated with irradiated B6 splenic cells (1 x 105) in the presence of a titrated dose of peptide (10, 1, and 0.1 µg/ml). Stimulation of hybridoma cells was measured by IL-2 production, as assayed by proliferation of HT-2 indicator cells. For each hybrid, the reactivity to the full-length peptide at a given dose was arbitrarily set at 100%. The response of the hybrids to the truncated peptides was compared with the response to the full-length Ep peptide. Reactivity against a peptide was graded as strong ({square}), weak (), or none ({blacksquare}), when IL-2 production from at least two of the three titrated doses was >50, 10–50, or <10%, respectively, of the IL-2 produced when the hybrid was stimulated with the full-length peptide. Cell cultures were performed in duplicate wells.

 
Ab/Ep-specific alloreactive and self-restricted T cells are equally sensitive to single amino acid substitutions in the Ep peptide

Finally, we compared the sensitivity of alloreactive and self-restricted hybrids to single amino acid substitutions in the Ep peptide. Prior studies examining peptide binding to H2-Ab and structural modeling suggested positions 58, 59, 61, 63, and 64 as possible contact points with self-restricted TCRs (52). We introduced substitutions in each of these positions, and in amino acid residues 55, 56, and 66. Residues in these positions were substituted to alanine, unless an alanine was already present, in which case the residue was substituted to glycine. Reactivities of the hybrids with these peptide variants were again graded as strong, weak, or none. Overall, the reactivities of the alloreactive and self-restricted hybrids to these peptide variants were very similar (Fig. 5Go). All hybrids reacted with the variant at amino acid position 66. A few hybrids from both allogeneic and syngeneic sources lost reactivity to peptide variants at positions 56, 59, and 64, and approximately half of all hybrids from each panel lost reactivity when changes were made at amino acid positions 55 and 63. The one exception to the pattern of similar fine specificity was noted at amino acid position 61. Substitution at this position resulted in loss of reactivity for 24% of the alloreactive hybrids and 55% of the self-restricted hybrids. Despite this small difference, these findings indicate similar fine specificity for peptide among alloreactive and self-restricted hybrids.



View larger version (32K):
[in this window]
[in a new window]
  		FIGURE 5. Self-restricted and alloreactive hybrids react similarly to variants of the Ep peptide with single amino acid substitutions. The indicated hybrids (1 x 105 cells) were incubated with irradiated B6 splenic cells (1 x 105) in the presence of a titrated dose of peptide (10, 1, and 0.1 µg/ml). Stimulation of hybridoma cells was measured by IL-2 production, as assayed by proliferation of HT-2 indicator cells. For each hybrid, the reactivity to the cognate Ep peptide was arbitrarily set at 100%. The response of the hybrids to the substituted peptides was compared with the response to the cognate Ep peptide. Sensitivities of the hybrids to the peptide variants were graded as strong ({square}), weak (), or none ({blacksquare}) as described in the legend to Fig. 4Go. Cell cultures were performed in duplicate wells.

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Peptide-dependence of alloreactive T cell responses

Our findings strongly support the peptide-dependent model of alloreactivity. While many studies have provided evidence for a critical role of peptides in the recognition of alloantigens by MHC class I-restricted CTL (5, 6, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27), few studies have investigated this issue for MHC class II molecules. This is mostly due to the lack of good experimental systems for the study of class II alloreactivity. Some early studies showed that the recognition of MHC class II by alloreactive CD4+ T cells could be partially inhibited by addition of exogenous Ags to the APCs (53, 54), and some alloreactive CD4+ T cells were shown to be able to distinguish between allogeneic MHC products expressed in different tissues (55, 56). A few examples of alloreactive MHC class II-restricted T cell clones with peptide-specificity are also available (37, 51, 57). The best evidence for a role of peptide in the class II system comes from studies with Ag-processing defective cells (51, 58). In one study, the alloresponse was measured against HLA-DM-deficient T2 cells transfected with mouse class II molecules (58). However, there was a significant amount of uncertainty regarding the nature and complexity of the peptides bound by class II molecules in these transfected cells. In another study, the allo response was measured against cells from H2-DM-deficient mice that mostly express CLIP peptides on their class II molecules (51), but again, not all class II molecules in these mice are bound by CLIP (45, 46). The experimental system used here does not have this limitation, because it is well-established that AbEpIi- mice express only a single peptide species (Ep) on their class II molecules (7, 45).

Of nearly 500 alloreactive T cell hybridomas that were generated against wild-type H2b-expressing cells in four different allogeneic strains, only a small fraction (6%) recognized the Ab/Ep complex expressed by these animals (Table IGo). This lack of reactivity was not just caused by the reduced expression of class II molecules in AbEpIi- mice, because most hybrids were able to react with cells from Ii-deficient mice that express similar class II surface levels. Therefore, these findings indicate that the majority of alloreactive T cells are peptide dependent. Among the hybrids that reacted with cells from AbEpIi- mice (6%), none recognized cells from H2-DM-deficient mice, indicating that they were not peptide independent. Conversely, among the hybrids that recognized H2-DM-deficient cells (9%), none reacted with AbEpIi- cells. Thus, among our large panel of alloreactive hybrids, no evidence was found for complete peptide independence.

The critical role of MHC-bound peptides for allorecognition was further demonstrated by using cells from AbEpIi- mice as stimulators of alloreactive T cell responses. In MLRs, these cells were very poor stimulators of naive alloreactive CD4+ T cells (Fig. 1Go). Further, among the alloreactive hybrids generated after immunization with cells from AbEpIi- mice, only 17% were exquisitely specific for the Ab/Ep complex (Table IIGo). Thus, peptide specificity of alloreactive T cells responses appears to be the exception rather than the rule. Most of the hybrids (83%) generated after immunization with cells from AbEpIi- mice not only reacted with AbEpIi- cells but also with wild-type B6 cells and/or Ii-deficient cells. Therefore, these hybrids cross-react with other peptides displayed by H2-Ab. While this type of reactivity may be consistent with peptide independence, only one of 13 hybrids tested within this group reacted weakly with H2-DM-deficient cells (Table IIGo), indicating that they are not truly peptide independent. Rather, these clones must be peptide dependent and significantly degenerate for recognition of peptide.

Overall, our findings indicate that peptide independence and peptide specificity are rare for alloreactive T cell responses. Instead, consistent with prior studies (19, 21, 22, 23), most alloreactive T cell clones appear to be peptide dependent and peptide degenerate. While peptide degeneracy has also been seen in self-restricted T cell responses (59), it appears to be more profound in alloreactive T cell responses. At the molecular level, this may indicate that a self-MHC/foreign peptide complex can be effectively mimicked by a wide variety of foreign MHC/self-peptide complexes.

One way by which peptides could affect allorecognition is by inducing subtle changes in the conformation of the {alpha}-helices of the MHC molecule that are recognized by the alloreactive TCR. Although crystallographic studies have not found any evidence for this possibility (58, 60), studies with conformation-dependent Abs have suggested that peptide binding can affect the conformation of MHC class I (61, 62) and class II (43, 44, 59, 63, 64, 65) molecules and that such subtly altered conformations can affect recognition by TCRs (57, 65, 66, 67). Our observation that none of the hybrids reactive with AbEpIi- cells recognized H2-DM-deficient cells, and vice versa (Table IGo), is consistent with this idea. These results also agree with the finding that some mAbs do not bind well with the Ab/Ep complex of AbEpIi- mice or the Ab/CLIP complex of H2-DM-deficient mice (Refs. 43 , 44 , and 65 ; our unpublished findings). This suggests that the conformations of these MHC-peptide complexes may be subtly different, which, in turn, may result in differential recognition by alloreactive T cells.

Strength of alloreactive T cell responses

Our findings may help to provide insight into the cellular and molecular basis for the overall strength of alloreactive responses, as compared with the weak responses typically seen for self-restricted T cells. One factor may by the degeneracy of alloreactive T cells for peptide recognition. As discussed above, most alloreactive T cells described here, except for those with exquisite peptide specificity, were highly degenerate for recognition of peptide. Another factor that may contribute to the overall strength of allo responses is the low activation threshold of these cells. In some prior studies, alloreactive T cell clones with very high avidity for foreign MHC have been identified (28, 29). Our studies support the idea that high reactivity is a general property of alloreactivity. Fig. 3Go shows that alloreactive hybrids, on average, were 10 times more sensitive to peptide stimulation than self-restricted hybrids. Thus, peptide degeneracy and high ligand sensitivity are two properties of alloreactive T cells that contribute to the strength of alloresponses.

Ligand requirements for alloreactive vs self-restricted T cells specific for the same MHC/peptide complex

Comparison of the fine specificity of Ab/Ep-specific alloreactive and self-restricted T cells indicated similar sensitivity to truncations (Fig. 4Go) and single amino acid substitutions (Fig. 5Go) of the Ep peptide. Several conclusions can be drawn from these observations. First, the alloreactive and self-restricted T cells must recognize Ep when it binds to Ab class II molecules in the same binding register. Second, the overall pattern of interactions of these TCRs with peptide residues is likely to be very similar, suggesting similar TCR contact points. Third, the overall orientation of these TCRs with respect to the MHC-peptide complex is likely to be identical or at least very similar and agrees with the idea that the diagonal footprint of TCRs with respect to MHC/peptide is likely to be conserved for all TCRs, including alloreactive ones (30, 31, 32, 33, 34, 35). Fourth, our findings indicate that alloreactive TCRs can be as specific to peptide as self-restricted TCRs. Some prior studies have suggested that alloreactive T cells, including peptide-specific alloreactive T cells, depend more strongly on interactions with residues of the {alpha}-helices of the MHC than with peptide residues (28, 35, 36, 37, 38). Two of these studies were performed by comparing the crystal structures of a TCR/self-MHC/peptide with a model for interaction of the same TCR with an allo-MHC/peptide ligand (35, 38). These models suggested increased interaction of the TCRs with residues of the allo-MHC. In some other studies, the specificity of a single TCR for recognition of allo- vs self-restricted ligand was compared (28, 36, 37). These studies suggested greater flexibility in the recognition of peptide bound to the allo-MHC as compared with peptide bound to the self-MHC. In contrast, our findings indicate similar peptide ligand requirements for peptide-specific alloreactive and self-restricted TCRs. This conclusion agrees with a recent study that compared the requirements for interaction with {alpha}-helical residues of the MHC among a panel of Ld-alloreactive and Ld-self-restricted CTL, including some peptide-specific alloreactive clones (39). These CTL were equally sensitive to changes in the sequence of the Ld molecule, indicating that alloreactive and self-restricted T cells are comparably dependent on MHC molecules. Our findings indicate that this conclusion can be also extended to the peptide requirements of alloreactive and self-restricted T cells.

Implications for T cell repertoire selection

The finding that alloreactive and self-restricted TCRs can react with a particular MHC/peptide ligand in a similar way has important implications for the role of positive selection in shaping the T cell repertoire. Positive selection induces the maturation of thymocytes with intermediate affinity for self-MHC and with a broad range of specificities. Previous studies that examined the alloreactive and self-restricted CTL responses against peptide libraries have suggested that the allo repertoire has a very wide diversity of specificities, perhaps as wide as that of the self-restricted T cell repertoire (68). Similarly, we demonstrated that peptide-specific alloreactive T cells can be readily obtained, indicating that there is no fundamental difference between the self-restricted and allo repertoire. The main difference between the self-restricted repertoire and the allo repertoire is that the former is more effective because cells with some specificity for self-MHC have been strongly enriched.


   Acknowledgments
 
We thank Hitesh Leva, Jie Wei, and David McFarland for technical support and members of our laboratory for critical reading of the manuscript.


   Footnotes
 
1 J.P.K. was supported in part by Medical Scientist Training Program Grant 5T32GM07347. Back

2 Current address: Institute of Molecular Medicine and Genetics, Medical College of Georgia, Augusta, GA 30912. Back

3 Current address: Department of Pathology, Emory University School of Medicine, Atlanta, GA 30322. Back

4 Current address: GeneMedicine, The Woodlands, TX 77381. Back

5 Address correspondence and reprint requests to Dr. Luc Van Kaer, Howard Hughes Medical Institute, Department of Microbiology and Immunology, Vanderbilt University School of Medicine, 811 Rudolph Light Hall, Nashville, TN 37232. Back

6 Abbreviations used in the paper: Ep, E{alpha}-derived peptide (aa 52–68); B6, C57BL/6; Ii, invariant chain; CLIP, class II-associated Ii chain peptide. Back

Received for publication March 3, 2000. Accepted for publication May 16, 2000.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Zinkernagel, R. M., P. C. Doherty. 1974. Restriction of in vitro T cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic of semiallogeneic system. Nature 248:701.[Medline]
  2. von Boehmer, H.. 1994. Positive selection of lymphocytes. Cell 76:219.[Medline]
  3. Robey, E., B. J. Fowlkes. 1994. Selective events in T cell development. Annu. Rev. Immunol. 12:675.[Medline]
  4. Jameson, S. C., K. A. Hogquist, M. J. Bevan. 1995. Positive selection of thymocytes. Annu. Rev. Immunol. 13:93.[Medline]
  5. Sherman, L. A., S. Chattopadhyay. 1993. The molecular basis of allorecognition. Annu. Rev. Immunol. 11:385.[Medline]
  6. Moller, G. 1997. Role of peptides in allorecognition. Immunol. Rev. 154.
  7. Ignatowicz, L., J. Kappler, P. Marrack. 1996. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 84:521.[Medline]
  8. Zerrahn, J., W. Held, D. H. Raulet. 1997. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88:627.[Medline]
  9. Bevan, M. J.. 1984. High determinant density may explain the phenomenon of alloreactivity. Immunol. Today 5:128.
  10. Elliott, T. J., H. N. Eisen. 1990. Cytotoxic T lymphocytes recognize a reconstituted class I histocompatibility antigen (HLA-A2) as an allogeneic target molecule. Proc. Natl. Acad. Sci. USA 87:5213.[Abstract/Free Full Text]
  11. Smith, P. A., A. Brunmark, M.R. Jackson, T. A. Potter. 1997. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL). J. Exp. Med. 185:1023.[Abstract/Free Full Text]
  12. Matzinger, P., M. J. Bevan. 1977. Why do so many lymphocytes respond to major histocompatibility antigens?. Cell. Immunol. 29:1.[Medline]
  13. Mentzer, S. J., J. A. Barbosa, J. L. Strominger, P. A. Biro, S. J. Burakoff. 1986. Species-restricted recognition of transfected HLA-A2 and HLA-B7 by human CTL clones. J. Immunol. 137:408.[Abstract]
  14. Bernhard, E. J., A. T. Le, J. R. Yannelli, M. J. Holterman, P. P. Hogan, V. H. Engelhard. 1987. The ability of cytotoxic T cells to recognize HLA-A2.1 or HLA-B7 antigens expressed on murine cells correlates with their epitope specificity. J. Immunol. 139:3614.[Abstract]
  15. Koller, T. D., C. Clayberger, J. L. Maryanski, and A. M. Krensky. 1987. Human allospecific cytolytic T lymphocyte lysis of a murine cell transfected with HLA-A2. J. Immunol. 138:2044.
  16. Heath, W. R., M. E. Hurd, F. R. Carbone, L. Sherman. 1989. Peptide-dependent recognition of H-2Kb by alloreactive cytotoxic T lymphocytes. Nature 341:749.[Medline]
  17. Aosai, F., C. Ohlen, H.-G. Ljunggren, P. Hoglund, L. Franksson, H. Ploegh, A. Townsend, K. Karre, H. J. Stauss. 1991. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells. Eur. J. Immunol. 21:2767.[Medline]
  18. Heath, W. R., K. P. Kane, M. F. Mescher, L. A. Sherman. 1991. Alloreactive T cells discriminate among a diverse set of endogenous peptides. Proc. Natl. Acad. Sci. USA 88:5101.[Abstract/Free Full Text]
  19. Crumpacker, D. B., J. Alexander, P. Cresswell, V. H. Engelhard. 1992. Role of endogenous peptides in murine allogeneic cytotoxic T cell responses assessed using transfectants of the antigen-processing mutant 174xCEM.T2. J. Immunol. 148:3004.[Abstract]
  20. Man, S., R. D. Salter, and V. H. Engelhard. 1992. Role of endogenous peptide in human alloreactive cytotoxic T cell responses. Int. Immunol. 4:367.
  21. Rotzschke, O., K. Falk, S. Faath, and H.-G. Rammensee. 1991. On the nature of peptides involved in T cell alloreactivity. J. Exp. Med. 174:1059.
  22. Kuzushima, K. R., G. M. Sun, Z. Vegh Van Bleek, S. G. Nathenson. 1995. The role of self peptides in the allogeneic cross-reactivity of CTLs. J. Immunol. 155:594.[Abstract]
  23. Wang, W., S. Man, P. H. Gulden, D. F. Hunt, V. H. Engelhard. 1998. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. J. Immunol. 160:1091.[Abstract/Free Full Text]
  24. Alexander-Miller, M. A., K. Burke, U. H. Koszinowski, T. Hansen, J. M. Connoly. 1993. Alloreactive cytotoxic T lymphocytes generated in the presence of viral-derived peptides show exquisite peptide and MHC specificity. J. Immunol. 151:1.[Abstract]
  25. Udaka, K., T. J. Tsomides, H. N. Eisen. 1992. A naturally occurring peptide recognized by alloreactive CD8+ cytotoxic T lymphocytes in association with a class I MHC protein. Cell 69:989.[Medline]
  26. Udaka, K., T. J. Tsomides, P. Walden, N. Fukusen, H. N. Eisen. 1993. A ubiquitous protein is the source of naturally occurring peptides that are recognized by a CD8+ T-cell clone. Proc. Natl. Acad. Sci. USA 90:11272.[Abstract/Free Full Text]
  27. Dabhi, V. M., R. Hovik, L. Van Kaer, K. Fischer Lindahl. 1998. The alloreactive T cell response against the class Ib molecule H2–M3 is specific for high affinity peptides. J. Immunol. 161:5171.[Abstract/Free Full Text]
  28. Sykulev, Y., A. Brunmark, T. J. Tsomides, S. Kageyama, M. Jackson, P. A. Peterson, H. N. Eisen. 1994. High affinity reactions between antigen-specific T-cell receptors and peptides associated with allogeneic and syngeneic major histocompatibility complex class I proteins. Proc. Natl. Acad. Sci. USA 91:11487.[Abstract/Free Full Text]
  29. Alberti, S.. 1995. A high affinity T cell receptor?. Immunol. Cell Biol. 74:292.
  30. Garcia, K. C., L. Teyton, I. A. Wilson. 1999. Structural basis of T cell recognition. Annu. Rev. Immunol. 17:369.[Medline]
  31. Garboczi, D. N., P. Ghosh, U. Utz, Q. R. Fan, W. E. Biddison, D. C. Wiley. 1996. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134.[Medline]
  32. Garcia, K. C., M. Degano, L. R. Pease, M. Huang, P. A. Peterson, L. Teyton, I. A. Wilson. 1998. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166.[Abstract/Free Full Text]
  33. Ding, Y. H., K. J. Smith, D. N. Garboczi, U. Utz, W. E. Biddison, D. C. Wiley. 1998. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8:403.[Medline]
  34. Ding, Y. H., B. M. Baker, D. N. Garboczi, W. E. Biddison, D. C. Wiley. 1999. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. Immunity 11:45.[Medline]
  35. Reinherz, E. L., K. Tan, L. Tang, P. Kern, J. Liu, Y. Xiong, R. E. Hussey, A. Smolyar, B. Hare, R. Zhang, et al 1999. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 286:1913.[Abstract/Free Full Text]
  36. Brock, R., K.-H. Wiesmuller, G. Jung, P. Walden. 1996. Molecular basis for the recognition of two structurally different major histocompatibility complex/peptide complexes by a single T-cell receptor. Proc. Natl. Acad. Sci. USA 93:13108.[Abstract/Free Full Text]
  37. Daniel, C., S. Horvath, P. M. Allen. 1998. A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR. Immunity 8:543.[Medline]
  38. Speir, J. A., K. C. Garcia, A. Brunmark, M. Degano, P. A. Peterson, L. Teyton, and I. A. Wilson. 1998. Structural basis of 2C TCR allorecognition of H-2Ld peptide complexes. Immunity 8:553.
  39. Hornell, T. M. C., J. C. Solheim, N. B. Myers, W. E. Gillanders, G. K. Balendiran, T. H. Hansen, J. M. Connolly. 1999. Alloreactive and syngeneic CTL are comparably dependent on interaction with MHC class I {alpha}-helical residues. J. Immunol. 163:3217.[Abstract/Free Full Text]
  40. Bikoff, E. K., L.-Y. Huang, V. Episkopou, J. van Meerwijk, R. N. Germain, E. J. Robertson. 1993. Defective major histocompatibility complex class II assembly, transport, peptide acquisition and CD4+ T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699.[Abstract/Free Full Text]
  41. Martin, W. D., G. G. Hicks, S. K. Mendiratta, H. I. Leva, H. E. Ruley, L. Van Kaer. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84543..
  42. Cosgrove, D., D. Gray, A. Dierich, J. Kaufman, M. Lemeur, C. Benoist, D. Mathis. 1992. Mice lacking MHC class II molecules. Cell 66:1051.
  43. Miyazaki, T., P. Wolf, S. Tourne, C. Waltzinger, A. Dierich, N. Barois, H. Ploegh, C. Benoist, D. Mathis. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531.[Medline]
  44. Fung-Leung, W. P., C. D. Surh, M. Liljedahl, J. Pang, D. Leturcq, P. A. Peterson, S. R. Webb, L. Karlsson. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278.[Abstract]
  45. Grubin, C. E., S. Kovats, P. DeRoos, A. Y. Rudensky. 1997. Deficient positive selection of CD4 T cells in mice displaying altered repertoires of self-peptides bound to MHC class II molecules. Immunity 7:197.[Medline]
  46. Tourne, S., T. Miyazaki, A. Oxenius, L. Klein, T. Fehr, B. Kyewski, C. Benoist, D. Mathis. 1997. Selection of a broad repertoire of CD4+ T cells in H-2 Ma0/0 mice. Immunity 7:187.[Medline]
  47. Viville, S., J. Neefjes, V. Lotteau, A Dierich, M. Lemeur, H. Ploegh, C. Benoist, and D. Mathis. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635.
  48. Elliott, E. A., J. R. Drake, S. Amigorena, J. Elsemore, P. Webster, I. Mellman, and R. A. Flavell. 1993. The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules. J. Exp. Med. 179:681.
  49. Bodmer, H., S. Viville, C. Benoist, and D. Mathis. 1994. Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. Science 263:1284.
  50. Grusby, M. J., R. S. Johnson, V. E. Papaioannou, L. H. Glimcher. 1991. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science 253:1417.[Abstract/Free Full Text]
  51. Mendiratta, S. K., J. P. Kovalik, S. Hong, N. Singh, W. D. Martin, L. Van Kaer. 1999. Peptide dependency of alloreactive CD4+ T cell responses. Int. Immunol. 11:351.[Abstract/Free Full Text]
  52. Ignatowicz, L., W. Rees, R. Pacholczyk, H. Ignatowicz, E. Kushnir, J. Kappler, P. Marrack. 1997. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity 7:179.[Medline]
  53. Rock, K. L., B. Benacerraf. 1984. Selective modification of a private I-A allo-stimulating determinant(s) upon association of antigen with an antigen-presenting cell. J. Exp. Med. 159:1238.[Abstract/Free Full Text]
  54. Eckels, D. D., J. Gorski, J. Rothbard, J. R. Lamb. 1988. Peptide-mediated modulation of T-cell allorecognition. Proc. Natl. Acad. Sci. USA 85:8191.[Abstract/Free Full Text]
  55. Marrack, P., J. Kappler. 1988. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature 332:840.[Medline]
  56. Lombardi, G., S. Sidhu, J. R. Lamb, J. R. Batchelor, R. I. Lechler. 1989. Co-recognition of endogenous antigen with HLA-DR1 by alloreactive human T cell clones. J. Immunol. 142:753.[Abstract]
  57. Panina-Bordignon, P., G. Corradin, E. Roosnek, A. Sette, A. Lanzavecchia. 1991. Recognition of class II alloreactive T cells of processed determinants from human serum proteins. Science 252:1548.[Abstract/Free Full Text]
  58. Fremont, D. H., M. Matsumura, E. A. Stura, P. A. Peterson, I. A. Wilson. 1992. Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. Science 257:919.[Abstract/Free Full Text]
  59. Mason, D. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19:395.
  60. Madden, D. R., D. N. Garboczi, and D. C. Wiley. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presentedby HLA-A2. Cell 75:603.
  61. Bluestone, J. A., S. Jameson, S. Miller, II R. Dick. 1992. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition. J. Exp. Med. 176:1757.[Abstract/Free Full Text]
  62. Catipovic, B., J. Dal Porte, M. Mage, T. E. Johansen, and J. P. Schneck. 1992. Major histocompatibility complex conformation epitopes are peptide specific. J. Exp. Med. 176:1611.
  63. Hogquist, K. A., A. G. Grandea, III, and M. J. Bevan. 1993. Peptide variants reveal how antibodies recognize major histocompatibility complex class I. Eur. J. Immunol. 23:3028.
  64. Rohren, E. M., D. J. McCormick, L. R. Pease. 1994. Peptide-induced conformational changes in class I molecules. J. Immunol. 152:5337.[Abstract]
  65. Chervonsky, A. V., R. M. Medzhitov, L. K. Denzin, A. K. Barlow, A. Y. Rudensky, and C. A. Janeway, Jr. 1998. Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides. Proc. Natl. Acad. Sci. USA 95:10094.
  66. Chen, W., J. McCluskey, S. Rodda, and F. R. Carbone. 1993. Changes at peptide residues buried in the major histocompatibility complex (MHC) class I binding cleft influence T cell recognition: a possible role for indirect conformational alterations in the MHC class I or bound peptide in determining T cell recognition. J. Exp. Med. 177:869.
  67. Chattopadhyay, S., M. Theobald, J. Biggs, and L. Sherman. 1994. Conformational differences in major histocompatibility complexes can result in alloreactivity. J. Exp. Med. 179:213.
  68. Obst, R., C. Munz, S. Stevanovic, H.-G. Rammensee. 1998. Allo- and self-restricted cytotoxic T lymphocytes against a peptide library: evidence for a functionally diverse allorestricted T cell repertoire. Eur. J. Immunol. 28:2432.[Medline]



This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
R. M. Nepal, B. Vesosky, J. Turner, and P. Bryant
DM, but not cathepsin L, is required to control an aerosol infection with Mycobacterium tuberculosis
J. Leukoc. Biol., October 1, 2008; 84(4): 1011 - 1018.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
N. J. Felix, A. Suri, J. J. Walters, S. Horvath, M. L. Gross, and P. M. Allen
I-Ep-Bound Self-Peptides: Identification, Characterization, and Role in Alloreactivity
J. Immunol., January 15, 2006; 176(2): 1062 - 1071.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kovalik, J.-P.
Right arrow Articles by Van Kaer, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kovalik, J.-P.
Right arrow Articles by Van Kaer, L.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS